A line extension of one of Sanofi Indias flagship brand Combiflam, the launch of this new product marks the companys foray into the OTC headache segment in India.On 11 November 2014, Sanofi India ...
Zacks.com on MSN7d
Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3BPfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...
Three years later, health and beauty brand L’Oreal acquired a majority ... but the company also develops over-the-counter medication as well. Sanofi now covers seven major therapeutic areas ...
Sanofi also claims Opella is also the third-largest business in the world in the over-the-counter vitamins ... a GlobalData owned brand. The information on this site has been included in good ...
With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...
Opella — Sanofi’s consumer healthcare ... which recently went viral for launching brand mascot Nigel the Owl. The success of Xyzal on TikTok underscores Opella’s creative commitment to breaking out of ...
It marks a significant change in direction for Ipsen, which has spent several years of building up the consumer health business through the acquisition of products from Sanofi, Boehringer ...
The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech ...
Lake County Record-Bee on MSN13d
College athletes can now make millions off sponsorship deals. Here’s the first look at California’s numbersCalifornia allowed college athletes to earn money, profiting off their name, image and likeness. University records show ...
In 2021, California enacted a law allowing athletes to make these kinds of brand deals ... for $300,000 and with the health care company Sanofi for $285,000. Fresno State shared less information.
In the latest move to cement its “immunology powerhouse” status, Sanofi is handing ove | The CD20-directed antibody, dubbed ...
Sanofi on Thursday announced an agreement with biopharmaceutical company Dren Bio for the acquisition of its autoimmune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback